Epigenomics AG is a holding company based in Berlin, Germany, dedicated to managing its own assets and investing in companies both domestically and internationally. Specializing in minimally invasive blood tests for cancer detection, the company also focuses on acquiring and disposing of investments in various sectors.
With a strong emphasis on corporate governance and financial transparency, Epigenomics AG has a Supervisory Board and Executive Board overseeing key decisions and appointments within the organization. The company regularly issues mandatory announcements and financial reports to keep shareholders and investors informed about its activities and developments in the market.
Generated from the website